For the first time, a blood test appears to predict with an impressive level of certainty whether patients will develop Alzheimer's disease within three years.
Debiopharm, the Swiss diagnostics and drug conglomerate, committed $6 million in new financing to a startup focused on developing a late-stage sepsis test.
Nanowerk reported that UCLA researchers have developed a Google Glass app that could enable instant, wireless diagnostic testing for HIV, types of cancer and other diseases.
Myriad Genetics is celebrating promising results from a study demonstrating the clinical utility of its Prolaris prostate cancer molecular diagnostic test. The Utah company hopes to use the data to win Medicare reimbursement for the test by this June.
Noninvasive prenatal blood tests are making a market splash--and Illumina's diagnostic might surpass the competition: A new study found that the company's innovative test for Down syndrome and other genetic abnormalities outperforms current screening methods, and reduces false-positive results when compared with traditional testing.
News that Abingworth has raised $375 million and sealed the deal for its 10th venture capital fund is a positive development for medical device, diagnostic and drug companies in a market where investment dollars are harder to come by.
The Galaxy S5 is soon to be the first smartphone on the market with a built-in heart rate monitor. The monitor is designed for fitness use, but according to South Korea's health agency, it may subject the highly anticipated new phone to med tech-level regulation before its maker, Samsung, can sell the phone in its own home country.
Researchers have found that CardioDx's genetic test for coronary artery disease could help physicians more accurately identify obstructive CAD in patients--and save insurance companies precious dollars.
Investors drove Foundation Medicine's stock up more than 10% during late morning trading on Feb. 26. What got them moving? They responded to news that the cancer diagnostic darling continued to grow revenue at a healthy clip as 2013 came to a close.
Cheetah Medical's diagnostic tech that helps measure blood flow has drawn in some investor love. The Newton, MA, company said it pulled in $9 million in new financing to help advance an international rollout.